BNTX - BioNTech SE

NasdaqGS - NasdaqGS Real-time price. Currency in USD
+2.84 (+9.28%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous close30.60
Bid0.00 x 3200
Ask0.00 x 1400
Day's range30.00 - 33.96
52-week range12.52 - 48.85
Avg. volume221,054
Market cap7.584B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings date13 Nov 2019
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est28.25
  • Biotech Stock Roundup: Updates From HZNP & CLVS, BioNTech to Acquire Neon

    Biotech Stock Roundup: Updates From HZNP & CLVS, BioNTech to Acquire Neon

    A low-key week for the biotech sector with a few pipeline and regulatory updates.

  • Reuters

    European biotech firm BioNTech reverses course in early trading

    Shares of BioNTech SE tumbled nearly 12% in afternoon trade, erasing all its gains from earlier on Thursday, another sign of weakness in the IPO market after the collapse of WeWork's market debut. The shares backpedalled even though the German biotech firm downsized its initial public offering (IPO) and priced its stock below an earlier expected range on Wednesday. A bout of stock market volatility fuelled by worries over the potential economic impact of a trade war between the United States and China has led to IPO hopefuls delaying their listings or shares of those recently listed floundering.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more